Mary Patricia Mullen, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 36 | 2024 | 1605 | 5.040 |
Why?
|
Echocardiography | 5 | 2024 | 5043 | 0.880 |
Why?
|
Ventricular Pressure | 1 | 2024 | 210 | 0.880 |
Why?
|
Vein of Galen Malformations | 1 | 2023 | 58 | 0.800 |
Why?
|
Family Relations | 2 | 2014 | 318 | 0.770 |
Why?
|
Pulmonary Artery | 6 | 2021 | 1949 | 0.760 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2023 | 216 | 0.760 |
Why?
|
Bronchopulmonary Dysplasia | 6 | 2024 | 329 | 0.690 |
Why?
|
Tachycardia, Supraventricular | 1 | 2022 | 273 | 0.660 |
Why?
|
Lung Diseases | 3 | 2024 | 1926 | 0.600 |
Why?
|
Vascular Resistance | 2 | 2019 | 941 | 0.540 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2022 | 645 | 0.520 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2019 | 477 | 0.520 |
Why?
|
Lung Transplantation | 4 | 2022 | 1310 | 0.490 |
Why?
|
T-Box Domain Proteins | 3 | 2023 | 473 | 0.480 |
Why?
|
Ventricular Function, Right | 3 | 2024 | 629 | 0.480 |
Why?
|
Heart Defects, Congenital | 8 | 2022 | 4713 | 0.470 |
Why?
|
Infant | 26 | 2024 | 36497 | 0.450 |
Why?
|
Scurvy | 1 | 2013 | 36 | 0.440 |
Why?
|
Survivors | 1 | 2024 | 2381 | 0.430 |
Why?
|
Adaptation, Psychological | 2 | 2014 | 2665 | 0.420 |
Why?
|
Stents | 2 | 2023 | 3204 | 0.420 |
Why?
|
Infant, Premature, Diseases | 3 | 2022 | 712 | 0.410 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2013 | 56 | 0.400 |
Why?
|
Chylothorax | 1 | 2013 | 83 | 0.400 |
Why?
|
Infant, Newborn | 22 | 2024 | 26395 | 0.390 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2022 | 278 | 0.390 |
Why?
|
Child | 32 | 2024 | 80863 | 0.380 |
Why?
|
Vasodilator Agents | 5 | 2022 | 991 | 0.370 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 2 | 2012 | 142 | 0.360 |
Why?
|
Lung Abscess | 1 | 2010 | 40 | 0.340 |
Why?
|
Parents | 2 | 2014 | 3596 | 0.340 |
Why?
|
Heart Ventricles | 4 | 2024 | 3839 | 0.340 |
Why?
|
Angioplasty, Balloon | 1 | 2013 | 592 | 0.310 |
Why?
|
Epoprostenol | 2 | 2020 | 248 | 0.310 |
Why?
|
Pulmonary Atresia | 1 | 2010 | 159 | 0.310 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2013 | 600 | 0.310 |
Why?
|
Activin Receptors, Type II | 1 | 2009 | 123 | 0.310 |
Why?
|
Child, Preschool | 19 | 2024 | 42623 | 0.280 |
Why?
|
Angiography | 1 | 2011 | 1598 | 0.250 |
Why?
|
Retrospective Studies | 21 | 2024 | 81834 | 0.240 |
Why?
|
Abnormalities, Multiple | 2 | 2010 | 1424 | 0.240 |
Why?
|
Tetralogy of Fallot | 1 | 2010 | 628 | 0.230 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 1389 | 0.220 |
Why?
|
Cardiac Surgical Procedures | 2 | 2010 | 3682 | 0.220 |
Why?
|
Down Syndrome | 2 | 2022 | 914 | 0.220 |
Why?
|
Ductus Arteriosus | 1 | 2023 | 42 | 0.220 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2015 | 1482 | 0.200 |
Why?
|
Humans | 60 | 2024 | 768451 | 0.200 |
Why?
|
Quality of Life | 2 | 2014 | 13497 | 0.200 |
Why?
|
Nitric Oxide | 3 | 2023 | 2146 | 0.200 |
Why?
|
Registries | 5 | 2022 | 8373 | 0.190 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2023 | 217 | 0.190 |
Why?
|
Prostaglandins | 1 | 2022 | 398 | 0.180 |
Why?
|
Heparin | 1 | 2008 | 1636 | 0.180 |
Why?
|
Exercise Test | 3 | 2024 | 2186 | 0.180 |
Why?
|
Thrombocytopenia | 1 | 2008 | 1183 | 0.170 |
Why?
|
Truncus Arteriosus, Persistent | 1 | 2020 | 63 | 0.170 |
Why?
|
Genetic Association Studies | 2 | 2022 | 2742 | 0.170 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2019 | 117 | 0.170 |
Why?
|
Adolescent | 17 | 2024 | 89168 | 0.170 |
Why?
|
Actigraphy | 1 | 2023 | 526 | 0.160 |
Why?
|
Current Procedural Terminology | 1 | 2020 | 101 | 0.160 |
Why?
|
Male | 31 | 2024 | 364781 | 0.160 |
Why?
|
Veins | 1 | 2023 | 767 | 0.160 |
Why?
|
Pediatric Nursing | 1 | 2019 | 104 | 0.150 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 471 | 0.150 |
Why?
|
Phenotype | 6 | 2023 | 16712 | 0.150 |
Why?
|
End Stage Liver Disease | 1 | 2022 | 370 | 0.140 |
Why?
|
Female | 31 | 2024 | 396943 | 0.140 |
Why?
|
Acute Disease | 2 | 2023 | 7246 | 0.140 |
Why?
|
Prevalence | 3 | 2024 | 15880 | 0.140 |
Why?
|
Electronic Health Records | 3 | 2020 | 4877 | 0.140 |
Why?
|
Antihypertensive Agents | 2 | 2020 | 2028 | 0.140 |
Why?
|
Exercise | 4 | 2024 | 5940 | 0.140 |
Why?
|
Endothelium-Dependent Relaxing Factors | 1 | 2015 | 21 | 0.130 |
Why?
|
Pulmonary Circulation | 1 | 2019 | 744 | 0.130 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2015 | 64 | 0.120 |
Why?
|
Semantics | 1 | 2019 | 617 | 0.120 |
Why?
|
Gastroesophageal Reflux | 1 | 2022 | 833 | 0.120 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2019 | 518 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3207 | 0.120 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2228 | 0.120 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2017 | 408 | 0.120 |
Why?
|
Treatment Outcome | 8 | 2023 | 65409 | 0.110 |
Why?
|
Safety Management | 1 | 2019 | 764 | 0.110 |
Why?
|
Clinical Protocols | 1 | 2019 | 1444 | 0.110 |
Why?
|
Iloprost | 1 | 2013 | 25 | 0.110 |
Why?
|
Medication Errors | 1 | 2019 | 783 | 0.110 |
Why?
|
Heart Valve Diseases | 1 | 2020 | 1033 | 0.100 |
Why?
|
Anticoagulants | 1 | 2008 | 4840 | 0.100 |
Why?
|
Lung Diseases, Interstitial | 1 | 2021 | 935 | 0.100 |
Why?
|
Data Mining | 1 | 2017 | 561 | 0.100 |
Why?
|
Heart Arrest | 1 | 2022 | 1516 | 0.100 |
Why?
|
Psychology | 1 | 2014 | 356 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2674 | 0.100 |
Why?
|
Lung | 5 | 2024 | 10090 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15965 | 0.090 |
Why?
|
Tropomyosin | 1 | 1991 | 106 | 0.090 |
Why?
|
Natural Language Processing | 1 | 2020 | 1197 | 0.090 |
Why?
|
Follow-Up Studies | 6 | 2024 | 39430 | 0.090 |
Why?
|
Young Adult | 8 | 2024 | 60045 | 0.090 |
Why?
|
Pediatrics | 2 | 2019 | 3622 | 0.090 |
Why?
|
Sulfones | 1 | 2012 | 448 | 0.090 |
Why?
|
Liver Transplantation | 1 | 2022 | 2399 | 0.090 |
Why?
|
Disease Management | 2 | 2017 | 2533 | 0.080 |
Why?
|
Pedigree | 3 | 2021 | 4545 | 0.080 |
Why?
|
Bayes Theorem | 1 | 2017 | 2358 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2696 | 0.080 |
Why?
|
Insurance, Health | 2 | 2020 | 2513 | 0.080 |
Why?
|
Sampling Studies | 1 | 2010 | 617 | 0.080 |
Why?
|
Platelet Factor 4 | 1 | 2008 | 132 | 0.070 |
Why?
|
Genotype | 1 | 2022 | 13047 | 0.070 |
Why?
|
Surface-Active Agents | 1 | 2007 | 152 | 0.070 |
Why?
|
Respiratory Tract Diseases | 1 | 2013 | 749 | 0.070 |
Why?
|
Genes | 1 | 1991 | 1824 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 18048 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2932 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2018 | 2145 | 0.070 |
Why?
|
Fontan Procedure | 1 | 2013 | 805 | 0.070 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1107 | 0.070 |
Why?
|
Quantitative Trait Loci | 1 | 2014 | 2127 | 0.070 |
Why?
|
RNA Splicing | 1 | 1991 | 906 | 0.070 |
Why?
|
Hemodynamics | 2 | 2022 | 4202 | 0.070 |
Why?
|
Infant, Premature | 3 | 2022 | 2124 | 0.060 |
Why?
|
Biopsy | 2 | 2024 | 6816 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2020 | 15880 | 0.060 |
Why?
|
Immunoglobulins | 1 | 2008 | 856 | 0.060 |
Why?
|
Exons | 1 | 1991 | 2392 | 0.060 |
Why?
|
Hernia, Diaphragmatic | 1 | 2005 | 244 | 0.060 |
Why?
|
Survival Analysis | 2 | 2019 | 10125 | 0.060 |
Why?
|
Reoperation | 2 | 2020 | 4342 | 0.060 |
Why?
|
Drainage | 1 | 2010 | 1179 | 0.060 |
Why?
|
Antibody Formation | 1 | 2008 | 1393 | 0.060 |
Why?
|
Neural Crest | 1 | 2005 | 279 | 0.050 |
Why?
|
Transcription Factors | 1 | 2023 | 12174 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2546 | 0.050 |
Why?
|
Algorithms | 4 | 2019 | 14158 | 0.050 |
Why?
|
Sulfonamides | 1 | 2011 | 1988 | 0.050 |
Why?
|
Caregivers | 1 | 2014 | 2302 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2013 | 3202 | 0.050 |
Why?
|
Administration, Inhalation | 2 | 2015 | 1170 | 0.050 |
Why?
|
Endostatins | 1 | 2021 | 168 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8611 | 0.050 |
Why?
|
Mutation | 2 | 2022 | 30243 | 0.040 |
Why?
|
Receptors, Interleukin-1 | 1 | 2021 | 262 | 0.040 |
Why?
|
Altitude | 1 | 2021 | 164 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4120 | 0.040 |
Why?
|
Lymphocytosis | 1 | 2021 | 121 | 0.040 |
Why?
|
Odds Ratio | 1 | 2013 | 9687 | 0.040 |
Why?
|
Pilot Projects | 1 | 2014 | 8730 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2021 | 22293 | 0.040 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2021 | 237 | 0.040 |
Why?
|
Leukocytosis | 1 | 2021 | 251 | 0.040 |
Why?
|
Health Personnel | 1 | 2014 | 3384 | 0.040 |
Why?
|
Regression Analysis | 2 | 2020 | 6353 | 0.040 |
Why?
|
Galectin 3 | 1 | 2021 | 240 | 0.040 |
Why?
|
Prospective Studies | 4 | 2023 | 54914 | 0.040 |
Why?
|
Neoplasms, Experimental | 1 | 1984 | 1232 | 0.040 |
Why?
|
Education, Nursing, Continuing | 1 | 2019 | 69 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 2000 | 404 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 2046 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2014 | 4538 | 0.040 |
Why?
|
Tracheostomy | 1 | 2022 | 433 | 0.040 |
Why?
|
Sarcomeres | 1 | 2000 | 378 | 0.040 |
Why?
|
Risk | 1 | 2010 | 9642 | 0.040 |
Why?
|
Classification | 1 | 2017 | 128 | 0.030 |
Why?
|
Postnatal Care | 1 | 2019 | 273 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2021 | 1697 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2010 | 20762 | 0.030 |
Why?
|
Homozygote | 1 | 2021 | 1779 | 0.030 |
Why?
|
Adult | 8 | 2019 | 223542 | 0.030 |
Why?
|
Genetic Testing | 1 | 2009 | 3586 | 0.030 |
Why?
|
Troponin T | 1 | 2000 | 787 | 0.030 |
Why?
|
North America | 1 | 2019 | 1292 | 0.030 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2015 | 80 | 0.030 |
Why?
|
Chronic Disease | 1 | 2010 | 9382 | 0.030 |
Why?
|
Standard of Care | 1 | 2019 | 571 | 0.030 |
Why?
|
Prognosis | 2 | 2017 | 30028 | 0.030 |
Why?
|
Genes, Dominant | 2 | 2012 | 856 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12875 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2000 | 843 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 13026 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8559 | 0.030 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2015 | 135 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2021 | 1660 | 0.030 |
Why?
|
United States | 5 | 2024 | 73121 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2014 | 474 | 0.030 |
Why?
|
Risk Assessment | 2 | 2017 | 24311 | 0.030 |
Why?
|
Patient Care Team | 1 | 2024 | 2526 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1751 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 41797 | 0.030 |
Why?
|
Heterozygote | 1 | 2019 | 2792 | 0.030 |
Why?
|
Tissue Donors | 1 | 2022 | 2377 | 0.030 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2015 | 417 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4861 | 0.020 |
Why?
|
Administration, Oral | 1 | 2020 | 4041 | 0.020 |
Why?
|
Gestational Age | 1 | 2021 | 3615 | 0.020 |
Why?
|
Prenatal Care | 1 | 2019 | 1159 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2015 | 633 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3234 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7471 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 2014 | 4622 | 0.020 |
Why?
|
Time Factors | 1 | 2013 | 40271 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7451 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 417 | 0.020 |
Why?
|
Cell-Free System | 1 | 1991 | 340 | 0.020 |
Why?
|
Fetus | 1 | 2018 | 1883 | 0.020 |
Why?
|
Restriction Mapping | 1 | 1991 | 851 | 0.020 |
Why?
|
Bronchiolitis Obliterans | 1 | 2012 | 220 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2950 | 0.020 |
Why?
|
Critical Illness | 1 | 2023 | 2754 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3237 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3471 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3906 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2013 | 993 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2015 | 849 | 0.020 |
Why?
|
Purines | 1 | 2012 | 614 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5152 | 0.020 |
Why?
|
Heart Failure | 1 | 2013 | 11857 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3412 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2014 | 1781 | 0.020 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2012 | 463 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2022 | 5371 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13655 | 0.020 |
Why?
|
Patient Readmission | 1 | 2022 | 3308 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3615 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2103 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2012 | 964 | 0.020 |
Why?
|
Middle Aged | 4 | 2014 | 223418 | 0.020 |
Why?
|
Curriculum | 1 | 2019 | 3778 | 0.020 |
Why?
|
Mice, Hairless | 1 | 1984 | 39 | 0.020 |
Why?
|
Cytogenetic Analysis | 1 | 2005 | 270 | 0.020 |
Why?
|
Animals | 4 | 2023 | 169418 | 0.010 |
Why?
|
PUVA Therapy | 1 | 1984 | 101 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2012 | 1669 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2723 | 0.010 |
Why?
|
Genetic Variation | 1 | 2019 | 6610 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 2013 | 1509 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 17647 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9505 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18478 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14766 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10601 | 0.010 |
Why?
|
Aged | 2 | 2014 | 171520 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36840 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14728 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3543 | 0.010 |
Why?
|
Nonmuscle Myosin Type IIB | 1 | 2000 | 21 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20231 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15460 | 0.010 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2000 | 286 | 0.010 |
Why?
|
Base Sequence | 1 | 1991 | 12428 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3278 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2012 | 3586 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12450 | 0.010 |
Why?
|
Pyrimidines | 1 | 1991 | 3050 | 0.010 |
Why?
|
Mice | 2 | 2021 | 82045 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 30179 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1991 | 7599 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2000 | 1527 | 0.010 |
Why?
|
Rats | 1 | 1991 | 23839 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2000 | 2594 | 0.010 |
Why?
|
DNA | 1 | 1984 | 7213 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13452 | 0.000 |
Why?
|
Myocardium | 1 | 2000 | 4788 | 0.000 |
Why?
|
Ultrasonography | 1 | 2000 | 5995 | 0.000 |
Why?
|